Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

PX404 Campylobacter jejuni Cas9 Citations (6)

Originally described in: Feng Zhang lab bacterial Cas9 orthologs
Unpublished

Articles Citing PX404 Campylobacter jejuni Cas9

Articles
A Broad-Spectrum Inhibitor of CRISPR-Cas9. Harrington LB, Doxzen KW, Ma E, Liu JJ, Knott GJ, Edraki A, Garcia B, Amrani N, Chen JS, Cofsky JC, Kranzusch PJ, Sontheimer EJ, Davidson AR, Maxwell KL, Doudna JA. Cell. 2017 Sep 7;170(6):1224-1233.e15. doi: 10.1016/j.cell.2017.07.037. Epub 2017 Aug 24. PubMed
Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing. Garcia B, Lee J, Edraki A, Hidalgo-Reyes Y, Erwood S, Mir A, Trost CN, Seroussi U, Stanley SY, Cohn RD, Claycomb JM, Sontheimer EJ, Maxwell KL, Davidson AR. Cell Rep. 2019 Nov 12;29(7):1739-1746.e5. doi: 10.1016/j.celrep.2019.10.017. PubMed

Associated Plasmids

Comparison of CRISPR/Cas Endonucleases for in vivo Retinal Gene Editing. Li F, Wing K, Wang JH, Luu CD, Bender JA, Chen J, Wang Q, Lu Q, Nguyen Tran MT, Young KM, Wong RCB, Pebay A, Cook AL, Hung SSC, Liu GS, Hewitt AW. Front Cell Neurosci. 2020 Sep 10;14:570917. doi: 10.3389/fncel.2020.570917. eCollection 2020. PubMed
Adenine base editing of the DUX4 polyadenylation signal for targeted genetic therapy in facioscapulohumeral muscular dystrophy. Sikrova D, Cadar VA, Ariyurek Y, Laros JFJ, Balog J, van der Maarel SM. Mol Ther Nucleic Acids. 2021 Jun 1;25:342-354. doi: 10.1016/j.omtn.2021.05.020. eCollection 2021 Sep 3. PubMed
In vivo prime editing of a metabolic liver disease in mice. Bock D, Rothgangl T, Villiger L, Schmidheini L, Matsushita M, Mathis N, Ioannidi E, Rimann N, Grisch-Chan HM, Kreutzer S, Kontarakis Z, Kopf M, Thony B, Schwank G. Sci Transl Med. 2022 Mar 16;14(636):eabl9238. doi: 10.1126/scitranslmed.abl9238. Epub 2022 Mar 16. PubMed

Associated Plasmids

Base editing of the mutated TERT promoter inhibits liver tumor growth. Zhao G, Ma Q, Yang H, Jiang H, Xu Q, Luo S, Meng Z, Liu J, Zhu L, Lin Q, Li M, Fang J, Ma L, Qiu W, Mao Z, Lu Z. Hepatology. 2023 Nov 28. doi: 10.1097/HEP.0000000000000700. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.